Statements of Operations-Additional Information (Tables)

3 Months Ended

Sep. 30, 2024

Statements of Operations-Additional Information

Schedule of revenues disaggregated by major product category and geographic region

Net Sales by Product Type

	Three Months
For the Periods Ended September 30	2024		2023
Animal Health
MFAs and other	$	107,844	$	94,104
Nutritional specialties		42,649		40,210
Vaccines		32,030		26,216
Total Animal Health	$	182,523	$	160,530
Mineral Nutrition		59,062		56,026
Performance Products		18,847		14,793
Total	$	260,432	$	231,349

Net Sales by Region

	Three Months
For the Periods Ended September 30	2024		2023
United States	$	143,549	$	131,287
Latin America and Canada		71,151		58,703
Europe, Middle East and Africa		31,125		26,879
Asia Pacific		14,607		14,480
Total	$	260,432	$	231,349

Schedule of interest expense, net

	Three Months
For the Periods Ended September 30	2024		2023
Interest expense, net
Credit Facilities	$	6,200	$	5,101
2022 Term Loan		12		216
Amortization of debt issuance costs		367		260
Refinancing expense		1,960		—
Other		226		68
Interest expense		8,765		5,645
Interest income		(1,124)		(1,081)
	$	7,641	$	4,564

Schedule of depreciation and amortization

	Three Months
For the Periods Ended September 30	2024		2023
Depreciation and amortization
Depreciation of property, plant and equipment	$	6,742	$	6,431
Amortization of intangible assets		2,262		2,440
	$	9,004	$	8,871